Opportunities Through Oracle’s Phase Forward Acquisition

Opportunities Through Oracle's Phase Forward Acquisition

Discover. Prepare. Sell. Deliver.
Direct access to specialized enablement, sales resources, and more.
. .
Expanded opportunities to deliver solutions and services around a more complete SaaS-based offering
Improved data management, aggregation and analysis
Greater transparency into patient outcomes for value-based healthcare
New capabilities, by building on existing product offerings and integrating highly complementary technology

On April 16, 2010, Oracle announced that it has entered into an agreement to acquire Phase Forward, a leading provider of applications for life sciences companies and healthcare providers. The proposed transaction is subject to Phase Forward stockholder approval, regulatory approvals and other customary closing conditions. Until the transaction closes, each company will continue to operate independently, and it is business as usual.

The life sciences and healthcare industries continue to focus on improving patients' health and medical outcomes while addressing the cost of healthcare. With Phase Forward, Oracle expects to help health sciences customers better capture, access, manage and share clinical and medical data. Customers are expected to gain greater insight into patient outcomes during drug development while providing healthcare services. The complementary combination of Phase Forward and Oracle products is expected to accelerate the delivery of innovative therapies to patients and help control healthcare costs.

Read the press release

 E-mail this page  Printer View